Crispr Therapeutics shares owned by Nordea Investment Management Ab
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Nordea Investment Management Ab
from 13F filings
Historical chart of Nordea Investment Management Ab investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Nordea Investment Management Ab consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Nordea Investment Management Ab
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $4.9M | 125k | 39.18 |
| 2024-09-30 | $5.7M | 120k | 47.10 |
| 2024-06-30 | $6.9M | 127k | 54.36 |
| 2024-03-31 | $10M | 149k | 69.30 |
| 2023-12-31 | $6.7M | 106k | 63.23 |
| 2023-09-30 | $5.0M | 108k | 46.65 |
| 2023-06-30 | $5.5M | 95k | 57.59 |
| 2023-03-31 | $4.5M | 101k | 44.94 |
| 2022-12-31 | $4.0M | 102k | 39.70 |
| 2022-09-30 | $5.8M | 88k | 65.82 |
| 2022-06-30 | $5.4M | 89k | 60.79 |
| 2022-03-31 | $6.3M | 97k | 64.60 |
| 2021-12-31 | $7.5M | 94k | 80.22 |
| 2021-09-30 | $17M | 151k | 112.39 |
More positions owned by Nordea Investment Management Ab
View all positions for Nordea Investment Management Ab